赛诺菲招聘博士后,需生物标志物研究背景
2018/11/6 7:55:00学术经纬 学术经纬

    

    


     药明康德/报道

     太长不看版:点击“阅读原文”/“Read More”,即可访问原始招聘页面,并投递简历。

     We are seeking a scientist to support mass spectrometry-based targeted proteomics approaches for biomarker discovery/qualification to endorse clinical studies, diagnostics and toxicology. The primary responsibility will be development/optimization of the highly multiplexed quantitative assay of protein biomarkers (MRM proteomics, DIA proteomics) in complex biological samples such as blood, plasma, cerebrospinal fluid, urine and other fluids/tissues.

     Skills

     Employ in-depth technical knowledge in the field of analytical experiment design and execution often working independently to design and implement a series of experiments. A successful candidate must have strong organization skills and ability to write technical reports. The candidate will collaborate widely with biologists and internal colleagues to develop/execute sample preparation methods, design a mass spectrometry workflow, generate and summarize the proteomics data.

     The hands-on experience with various analytical/bioanalytical tools is essential. Experience in the area of MS-based proteomics including sample fractionation, protein digestion and recovery techniques for challenging protein mixtures are desired.

     Experience with data processing and proteomics database search is plus.

     Strong communication and writing skills are essential.

     Qualifications

     PhD in the area of life science (chemistry, biochemistry, etc.) with 0-2 years

     All candidates must have authorization to work in the United States throughout the duration of the Fellowship. No visa sponsorship will be provided

     #LI-SA

     #GD-SA

     Sanofi US Services, Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

     At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.

     本文来自药明康德微信团队,欢迎转发到朋友圈,谢绝转载到其他平台。如有开设白名单需求,请在文章底部留言。如有其他合作需求,请联系wuxi_media@wuxiapptec.com。

     癌症突破

     抗癌疫苗 | 癌症地图 | KRAS | 酒精 | CAR-T 2.0 | 单细胞CAR-T | 外泌体 | 白血病免疫疗法 | 膳食纤维与肝癌 | 中年危机

     智慧之光

     大脑逻辑 | 母爱 | 脑细胞 | 阿兹海默病血检 | 孤独 | 可乐 | 生酮饮食 | 阿兹海默病毒假说 | 大脑抗衰老 | 麦克阿瑟天才奖

     热门前沿

     膳食纤维 | 人工智能 | 耐寒 | 维生素D | 脂肪治疗 | 细菌耐药 | 性别逆转 | 延年益寿 | 细胞分裂 | 减肥新方 | 单染色体酵母 | 吃不胖的方法 | 精准医学 | 单性生殖 | 胚胎发育

    

    

    

    http://weixin.100md.com
返回 学术经纬 返回首页 返回百拇医药